Technology News and Research

RSS

PreCision Dermatology formed as a result of spin-out of Onset Therapeutics

PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.

2 Dec 2010

Argonne researchers awarded 65 million hours of computing time on Blue Gene/P supercomputer

Four researchers at the U.S. Department of Energy's (DOE) Argonne National Laboratory lead projects that have been awarded a total of 65 million hours of computing time on Argonne's energy-efficient Blue Gene/P ("Intrepid") supercomputer. The researchers will conduct advanced simulation and analysis, performing virtual experiments that would be almost impossible and impractical in the natural world. They will also develop scalable system software needed to fully harness the power of supercomputers.

2 Dec 2010

M*Modal partners with RadNet to provide advanced documentation capabilities

M*Modal and RadNet, Inc. announced today a partnership to integrate M*Modal's Speech Understanding technology into RadNet's radiology Information technology solutions.

2 Dec 2010

CAIRE enters definitive agreement to acquire SeQual

Chart Industries, Inc. announced that its wholly-owned subsidiary, CAIRE Inc., which operates under its BioMedical segment, has entered into a definitive agreement to acquire SeQual Technologies Inc. for approximately $40 million, plus the possibility of up to $20 million of additional future payments contingent on SeQual's financial performance over a two-year period post-closing.

2 Dec 2010

Advinus collaborates with Corning to bring Epic technology to India

Advinus Therapeutics, the research-based pharmaceutical company promoted by the TATA Group, and Corning Incorporated today announced a collaboration to bring Corning Epic label-free detection technology to India.

2 Dec 2010

NHS to develop new treatment options for patients with lung disease

Scientists and clinicians in Nottingham are to work more closely with industry to develop new ways of diagnosing and treating lung disease.

2 Dec 2010

Bottomline expert to discuss on disparate systems to eliminate paper in healthcare organizations

Bottomline Technologies, a leading provider of collaborative payment, invoice and document automation solutions, today announced it will provide insights and recommendations for healthcare organizations interested in eliminating paper from their business processes and saving time and money with a webinar co-sponsored by the Healthcare Information and Management Systems Society (HIMSS).

2 Dec 2010

APHP selects Bruker´s Biotyper as exclusive MALDI-TOF mass spectrometry for microbial identification

At the 30th Reunion Interdisciplinaire de Chimothérapie Anti-Infectieuse (RICAI), Bruker announces that the Assistance Publique Hôpitaux de Paris (APHP) has selected Bruker´s IVD MALDI Biotyper as their exclusive MALDI-TOF mass spectrometry-based microbial identification tool.

2 Dec 2010

Museum of Science recognizes RainDance for contributions to advance genetic research

RainDance Technologies, Inc., a private company pioneering microdroplet-based technologies for single molecule and single cell analysis, today announced that the company has been recognized by the Museum of Science, Boston and the Boston Patent Law Association for its innovations and contributions to advancing the field of genetic research.

2 Dec 2010

Baxter licenses Vero cell-based influenza vaccine technology to Takeda

Baxter International Inc. and Takeda Pharmaceutical Company Limited today announced that the parties have completed a Development, License and Technology Transfer Agreement. Under the terms of the agreement, Takeda and Baxter will expand upon their previously announced collaboration to bring Vero cell culture-based influenza vaccines to the Japanese market.

From Baxter International Inc. 2 Dec 2010

AMT, Amgen amend GDNF gene license agreement

Amsterdam Molecular Therapeutics Holding N.V., a leader in the development of gene-based therapies, today announced that it has amended and restated its licensing agreement with Amgen for gene therapy applications incorporating the GDNF (glial cell derived neurotrophic factor) gene, to which Amgen holds rights. Financial terms were not disclosed.

2 Dec 2010

New radiation-free device to detect breast cancer

A new device may enable breast cancer screening and cancer detection in populations where mammography is not widely available or successful, including women in developing countries, and those under the age of 40.

2 Dec 2010

Biomagnetics identifies second biomarker for tuberculosis assay

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced the identification of a second biomarker for development of a tuberculosis assay.

2 Dec 2010

Cellectis signs agreement with Harvard Apparatus for electroporation-based instruments

Cellectis, the French genome engineering specialist, and Harvard Apparatus, a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, have announced today that they have signed a license agreement that grants Harvard Apparatus the worldwide exclusive right to manufacture and sell, for research use, the full line of electroporation-based instruments acquired by Cellectis from CytoPulse in September of 2010.

2 Dec 2010

Genzyme sells genetics business to LabCorp for $925M

Genzyme Corporation today announced that it has completed the sale of Genzyme Genetics to Laboratory Corporation of America Holdings (NYSE: LH) for $925 million in cash.

2 Dec 2010

GE Healthcare launches eHealth Image Exchange software solution

GE Healthcare today announced its eHealth Image Exchange software solution: a flexible, standards-based platform for sharing images and integrating workflows across a healthcare community.

2 Dec 2010

Collegium completes spin-out of Onset Therapeutics

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has completed the spin-out of Onset Therapeutics, LLC, its wholly owned subsidiary focused on the Dermatology market.

2 Dec 2010

States struggle with significant financial budget strains, especially in Medicaid; Others position for innovative coverage efforts

Bloomberg: "U.S. states expect 'significant challenges' balancing budgets in the next two years, after closing $230 billion in gaps since 2009, as U.S. stimulus aid drops and tax receipts recover from the recession, a study said. While state spending is set to rise for the current fiscal year compared with 2010, after two straight annual declines, governments will face renewed pressure in 2012, according to the study released today by the National Governors Association. The budget period begins in July in 46 states.

2 Dec 2010

Researchers identify blip in gene that causes JMP syndrome

UT Southwestern Medical Center researchers have identified a gene responsible for a rare disease that results in severe joint stiffness, muscle loss, anemia and panniculitis-induced lipodystrophy, or JMP syndrome.

2 Dec 2010